NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

Such a manufacturing license is separate from any regulatory decision about approval of DCVax-L itself. The Company has not to date submitted an application for commercial approval of DCVax-L.

Would it not be possible to make this same statement, if the company has been submitting a BLA on a rolling basis, but not yet submitted the final segment? Presumably, the "application for commercial approval:" would only be made AFTER the submission of the last segment. So they could have most of the job done and still make this above statement.